ON-DEMAND WEBINAR
Unlocking innovation in cardiac drug discovery
Automation of 3D organoid culture powered by machine learning and advanced image analysis
Cardiovascular disease (CVD) remains a significant global health concern, accounting for 32% of all mortalities. The absence of reliable and representative human heart in vitro models poses a significant challenge in drug discovery, impeding the development of effective treatments.
In this presentation from SLAS EU 2025, discover a fully automated high-throughput platform for culturing induced pluripotent stem cells (iPSC) and differentiating them into 3D self-organizing cardiac organoids (cardioids).
Heading
Register to watch the on-demand webinar now
Product family
CX.ai
Product primary application
CellXpress.ai Automated Cell Culture System; Organoids
cmp
701Rn00000iwoKxIAI
Title
Unlocking innovation in cardiac drug discovery
Resource URL
Resource Image URL
